awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50102737-DF48DD79-46E9-4599-A500-6DFF60CE3648
Q50102737-DF48DD79-46E9-4599-A500-6DFF60CE3648
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50102737-DF48DD79-46E9-4599-A500-6DFF60CE3648
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.
P2860
Q50102737-DF48DD79-46E9-4599-A500-6DFF60CE3648
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50102737-DF48DD79-46E9-4599-A500-6DFF60CE3648
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb62d23b656030d6dd5379bbfeb8925764cc5215
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).